Incyte (INCY) shares have shown solid momentum over the past month, gaining 12% and delivering a 21% return over the past 3 months. The company continues to draw investor attention for its performance ...
A month has gone by since the last earnings report for Incyte (INCY). Shares have added about 17.2% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...
Greetings, and welcome to the Incyte Third Quarter 2025 Earnings Conference Call webcast [Operator Instructions]. As a reminder, this conference is being recorded. It's now my pleasure to turn the ...
Incyte Corporation's (NASDAQ:INCY) third-quarter revenue was $1.37 billion. The company beat the consensus of $1.26 billion. Total revenues increased 20% year over year, primarily driven by a rise in ...
Following the release of yesterday's Ultimate Spider-Man #22, there are only two issues to go before the series from writer Jonathan Hickman and artist Marco Chechetto reaches its conclusion. With the ...
Transaction value calculated using the SEC Form 4 weighted average purchase price ($85.85) as of the transaction date (October 3, 2025); Post-transaction value calculated using the SEC Form 4 weighted ...
Incyte Corporation (NASDAQ:INCY) ranks among the best biotech stocks to buy. RBC Capital retained its Sector Perform rating on Incyte Corporation (NASDAQ:INCY) and increased its price target from $72 ...
Incyte Corporation (NASDAQ:INCY) ranks among the most undervalued NASDAQ stocks to buy now. Citizens JMP reaffirmed its Market Perform rating on Incyte Corporation (NASDAQ:INCY) on September 18 after ...
For more than half a century, Spider-Man has done whatever a spider can — and more — across our TV screens in animated form. He has shaped generations of Marvel fans long before the MCU turned him ...
Hosted on MSN
Wells Fargo Upgrades Incyte (INCY)
Fintel reports that on August 6, 2025, Wells Fargo upgraded their outlook for Incyte (NasdaqGS:INCY) from Equal-Weight to Overweight. Analyst Price Forecast Suggests 6.78% Upside As of August 6, 2025, ...
Hosted on MSN
William Blair Downgrades Incyte (INCY)
Fintel reports that on March 18, 2025, William Blair downgraded their outlook for Incyte (NasdaqGS:INCY) from Outperform to Market Perform. Analyst Price Forecast Suggests 28.39% Upside As of March 4, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results